Table 3.
Associations between brachial-ankle pulse wave velocity and lipids with RC and other lipids entered into the model simultaneously.
| Variables | β (95% CI) | P-value | Variables | β (95% CI) | P-value |
|---|---|---|---|---|---|
| Comparison I * (when considered RC and LDL-C simultaneously) | |||||
| RC, mmol/L | LDL-C, mmol/L | ||||
| Q1 (<0.41) | 0 | Q1 ( ≤ 2.72) | 0 | ||
| Q2 (0.41–0.56) | 27.68 (9.14, 46.22) | 0.003 | Q2 (2.73–3.23) | −5.25 (−23.41, 12.91) | 0.571 |
| Q3 (0.56–0.73) | 64.01 (44.26, 83.76) | <0.001 | Q3 (3.24–3.78) | −2.72 (−21.60, 16.15) | 0.777 |
| Q4 (≥0.74) | 92.14 (71.63, 112.66) | <0.001 | Q4 (≥3.79) | −14.86 (−34.94, 5.21) | 0.147 |
| Comparison II * (when considered RC and TG simultaneously) | |||||
| RC, mmol/L | TG, mmol/L | ||||
| Q1 (< 0.41) | 0 | Q1 ( ≤ 0.90) | 0 | ||
| Q2 (0.41–0.56) | 16.05 (−3.39, 35.48) | 0.106 | Q2 (0.91–1.27) | 18.70 (−0.45, 37.85) | 0.056 |
| Q3 (0.56–0.73) | 39.99 (17.67, 62.31) | <0.001 | Q3 (1.28–1.82) | 25.51 (3.31, 47.71) | 0.024 |
| Q4 (≥0.74) | 51.02 (23.87, 78.17) | <0.001 | Q4 (≥1.83) | 50.53 (23.34, 77.72) | <0.001 |
| Comparison III * (when considered RC and HDL-C simultaneously) | |||||
| RC, mmol/L | HDL-C, mmol/L | ||||
| Q1 (< 0.41) | 0 | Q1 ( ≤ 1.16) | 0 | ||
| Q2 (0.41–0.56) | 23.69 (5.40, 41.98) | 0.011 | Q2 (1.17–1.39) | 1.67 (−16.79, 20.12) | 0.860 |
| Q3 (0.56–0.73) | 56.68 (37.41, 75.74) | <0.001 | Q3 (1.40–1.65) | −13.84 (−13.56, 5.88) | 0.169 |
| Q4 (≥0.74) | 81.38 (60.80, 101.95) | < 0.001 | Q4 (≥1.66) | −8.16 (−29.88, 13.56) | 0.462 |
| Comparison IV * (when considered RC and TC simultaneously) | |||||
| RC, mmol/L | TC, mmol/L | ||||
| Q1 (<0.41) | 0 | Q1 ( ≤ 4.69) | 0 | ||
| Q2 (0.41–0.56) | 26.39 (8.05, 44.72) | 0.005 | Q2 (4.70–5.27) | −9.92 (−28.10, 8.25) | 0.285 |
| Q3 (0.56–0.73) | 61.58 (42.13, 81.03) | <0.001 | Q3 (5.28–5.94) | 2.07 (−16.76, 20.91) | 0.829 |
| Q4 (≥0.74) | 89.95 (69.05, 110.86) | <0.001 | Q4 (≥5.95) | −11.20 (−31.55, 9.16) | 0.281 |
| Comparison V * (when considered RC and Non-HDL-C simultaneously) | |||||
| RC, mmol/L | Non-HDL-C, mmol/L | ||||
| Q1 (< 0.41) | 0 | Q1 ( ≤ 3.23) | 0 | ||
| Q2 (0.41–0.56) | 29.43 (10.19, 48.67) | 0.003 | Q2 (3.23–3.84) | −2.52 (−21.46, 16.43) | 0.795 |
| Q3 (0.56–0.73) | 66.93 (45.56, 88.30) | <0.001 | Q3 (3.85–4.50) | −15.0 (−35.74, 5.71) | 0.156 |
| Q4 (≥0.74) | 95.37 (71.60, 119.13) | <0.001 | Q4 (≥4.51) | −11.42 (−34.49, 11.65) | 0.332 |
*
Adjusted for sex, age, BMI, eGFR, smoking, drinking, hypertension history, diabetes history, and myocardial infarction history.
CI, confidence interval; Q, quartile; BMI, body mass index; eGFR, estimated glomerular filtration rate; TC, total cholesterol; TG, triglyceride; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; RC, remnant cholesterol.